Annual EBIT:
$1.29B-$199.71M(-13.38%)Summary
- As of today, RPRX annual earnings before interest & taxes is $1.29 billion, with the most recent change of -$199.71 million (-13.38%) on December 31, 2024.
- During the last 3 years, RPRX annual EBIT has fallen by -$138.27 million (-9.66%).
- RPRX annual EBIT is now -50.73% below its all-time high of $2.62 billion, reached on December 31, 2019.
Performance
RPRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$427.16M+$217.36M(+103.60%)Summary
- As of today, RPRX quarterly earnings before interest & taxes is $427.16 million, with the most recent change of +$217.36 million (+103.60%) on September 30, 2025.
- Over the past year, RPRX quarterly EBIT has dropped by -$307.92 million (-41.89%).
- RPRX quarterly EBIT is now -67.93% below its all-time high of $1.33 billion, reached on December 31, 2019.
Performance
RPRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$1.53B-$307.92M(-16.73%)Summary
- As of today, RPRX TTM earnings before interest & taxes is $1.53 billion, with the most recent change of -$307.92 million (-16.73%) on September 30, 2025.
- Over the past year, RPRX TTM EBIT has dropped by -$11.79 million (-0.76%).
- RPRX TTM EBIT is now -41.86% below its all-time high of $2.64 billion, reached on June 30, 2020.
Performance
RPRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RPRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -13.4% | -41.9% | -0.8% |
| 3Y3 Years | -9.7% | +122.2% | +62.5% |
| 5Y5 Years | -50.7% | -16.3% | -41.4% |
RPRX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -13.4% | +40.0% | -41.9% | +679.0% | -19.4% | +66.0% |
| 5Y | 5-Year | -50.7% | +40.0% | -42.7% | +679.0% | -41.4% | +66.0% |
| All-Time | All-Time | -50.7% | +78.8% | -67.9% | +679.0% | -41.9% | +255.6% |
RPRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $427.16M(+103.6%) | $1.53B(-16.7%) |
| Jun 2025 | - | $209.80M(-60.7%) | $1.84B(-3.1%) |
| Mar 2025 | - | $534.18M(+48.0%) | $1.90B(+47.1%) |
| Dec 2024 | $1.29B(-13.4%) | $361.00M(-50.9%) | $1.29B(-16.3%) |
| Sep 2024 | - | $735.07M(+172.6%) | $1.54B(+60.8%) |
| Jun 2024 | - | $269.63M(+465.5%) | $960.30M(+2.2%) |
| Mar 2024 | - | -$73.77M(-112.0%) | $939.51M(-37.0%) |
| Dec 2023 | $1.49B(+61.7%) | $613.00M(+304.8%) | $1.49B(+47.4%) |
| Sep 2023 | - | $151.44M(-39.1%) | $1.01B(-3.9%) |
| Jun 2023 | - | $248.84M(-48.0%) | $1.05B(-10.9%) |
| Mar 2023 | - | $478.97M(+260.1%) | $1.18B(+28.1%) |
| Dec 2022 | $922.89M(-35.5%) | $133.00M(-30.8%) | $922.72M(-2.1%) |
| Sep 2022 | - | $192.21M(-49.1%) | $942.72M(-10.5%) |
| Jun 2022 | - | $377.79M(+71.9%) | $1.05B(-25.8%) |
| Mar 2022 | - | $219.72M(+43.6%) | $1.42B(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.43B(-10.3%) | $153.00M(-49.5%) | $1.43B(-10.1%) |
| Sep 2021 | - | $303.05M(-59.3%) | $1.59B(-11.5%) |
| Jun 2021 | - | $744.95M(+224.9%) | $1.80B(+22.9%) |
| Mar 2021 | - | $229.30M(-27.0%) | $1.46B(-8.3%) |
| Dec 2020 | $1.60B(-39.2%) | $314.00M(-38.5%) | $1.60B(-39.0%) |
| Sep 2020 | - | $510.57M(+24.7%) | $2.61B(-0.8%) |
| Jun 2020 | - | $409.35M(+13.3%) | $2.64B(+3.2%) |
| Mar 2020 | - | $361.43M(-72.9%) | $2.55B(-2.6%) |
| Dec 2019 | $2.62B(+92.3%) | $1.33B(+150.1%) | $2.62B(+103.1%) |
| Sep 2019 | - | $532.50M(+62.4%) | $1.29B(+70.2%) |
| Jun 2019 | - | $327.86M(-23.9%) | $758.76M(+76.1%) |
| Mar 2019 | - | $430.90M | $430.90M |
| Dec 2018 | $1.36B(+45.2%) | - | - |
| Dec 2017 | $939.69M(+30.0%) | - | - |
| Dec 2016 | $722.87M(-9.0%) | - | - |
| Dec 2015 | $794.28M | - | - |
FAQ
- What is Royalty Pharma plc annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Royalty Pharma plc?
- What is Royalty Pharma plc annual EBIT year-on-year change?
- What is Royalty Pharma plc quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly EBIT year-on-year change?
- What is Royalty Pharma plc TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Royalty Pharma plc?
- What is Royalty Pharma plc TTM EBIT year-on-year change?
What is Royalty Pharma plc annual earnings before interest & taxes?
The current annual EBIT of RPRX is $1.29B
What is the all-time high annual EBIT for Royalty Pharma plc?
Royalty Pharma plc all-time high annual earnings before interest & taxes is $2.62B
What is Royalty Pharma plc annual EBIT year-on-year change?
Over the past year, RPRX annual earnings before interest & taxes has changed by -$199.71M (-13.38%)
What is Royalty Pharma plc quarterly earnings before interest & taxes?
The current quarterly EBIT of RPRX is $427.16M
What is the all-time high quarterly EBIT for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly earnings before interest & taxes is $1.33B
What is Royalty Pharma plc quarterly EBIT year-on-year change?
Over the past year, RPRX quarterly earnings before interest & taxes has changed by -$307.92M (-41.89%)
What is Royalty Pharma plc TTM earnings before interest & taxes?
The current TTM EBIT of RPRX is $1.53B
What is the all-time high TTM EBIT for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM earnings before interest & taxes is $2.64B
What is Royalty Pharma plc TTM EBIT year-on-year change?
Over the past year, RPRX TTM earnings before interest & taxes has changed by -$11.79M (-0.76%)